Sex differences in [11C]ABP688 binding: a positron emission tomography study of mGlu5 receptors

Eur J Nucl Med Mol Imaging. 2019 May;46(5):1179-1183. doi: 10.1007/s00259-018-4252-4. Epub 2019 Jan 9.

Abstract

Purpose: The purpose of this study was to assess, in a large sample of healthy young adults, sex differences in the binding potential of [11C]ABP688, a positron emission tomography (PET) tracer selective for the metabotropic glutamate type 5 (mGlu5) receptor.

Methods: High resolution [11C]ABP688 PET scans were acquired in 74 healthy volunteers (25 male, 49 female, mean age 20 ± 3.0). Mean binding potential (BPND = fND * (Bavail / KD)) values were calculated in the prefrontal cortex, striatum, and limbic regions using the simplified reference tissue model with cerebellar grey matter as the reference region.

Results: [11C]ABP688 BPND was significantly higher in men compared to women in the prefrontal cortex (p < 0.01), striatum (p < 0.001), and hippocampus (p < 0.05). Whole-brain BPND was 17% higher in men. BPND was not related to menstrual phase in women.

Conclusions: Binding availability of mGlu5 receptors as measured by PET [11C]ABP688 is higher in healthy men than women. This likely represents a source of variability in [11C]ABP688 studies and could have relevance for sex differences in cognitive-behavioral functions and neuropsychiatric disorders.

Keywords: Gender; Metabotropic glutamate receptors; PET; mGluR5.

MeSH terms

  • Brain / diagnostic imaging
  • Brain / metabolism
  • Carbon Radioisotopes*
  • Female
  • Healthy Volunteers
  • Humans
  • Male
  • Oximes / metabolism*
  • Positron-Emission Tomography*
  • Protein Binding
  • Pyridines / metabolism*
  • Receptor, Metabotropic Glutamate 5 / metabolism*
  • Sex Characteristics*
  • Young Adult

Substances

  • 3-(6-methylpyridin-2-ylethynyl)cyclohex-2-enone-O-methyloxime
  • Carbon Radioisotopes
  • Carbon-11
  • Oximes
  • Pyridines
  • Receptor, Metabotropic Glutamate 5